Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01373671 · ClinicalTrials.gov registry record · NA

Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging

A NA study of Breast Cancer, sponsored by Siemens Medical Solutions USA - CSG.

Completed
Registry status
NA
Development phase
764
Enrollment target
1
Study location

NCT01373671: Completed NA study of Breast Cancer, sponsored by Siemens Medical Solutions USA - CSG.

NCT01373671 is a NA study of Breast Cancer that has completed, run by Siemens Medical Solutions USA - CSG. The registered enrollment target is 764 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01373671, a NA study of Breast Cancer, has completed, sponsored by Siemens Medical Solutions USA - CSG.

COMPLETED
Registry status
NA
Development phase
764 participants
Enrollment target
1
Study location

Study Summary

The primary objective of this protocol is to collect the 2-dimensional (2D) screening and diagnostic images, and 3-dimensional (3D) Digital Breast Tomosynthesis (DBT) scans from patient mammography examinations acquired on various commercially available Full Field Digital Mammography (FFDM) systems and the Siemens Inspiration DBT system, respectively.

Primary Outcome

The primary objective of this study was to demonstrate the superiority of DBT and FFDM images together in comparison to FFDM images alone with respect to the ability of readers to detect and diagnose malignant lesions. A comparison of the breast-level ROC areas was used to evaluate the superiority of DBT as an adjunct to FFDM vs. FFDM alone.

Conditions Studied

Interventions

  • DEVICE SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM

Study Locations (1)

Pennsylvania

  • Siemens Medical Solutions - Malvern

Trial Details

FieldValue
Enrollment Target 764 participants
Start Date 2011-05
Est. Completion 2014-05
Phase NA

What the finished NCT01373671 record still lists

NCT01373671 is an interventional study that assigns participants to a tested intervention. The registered 764 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM is the first listed.

NCT01373671 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01373671 about?

NCT01373671 is a clinical study titled "Evaluation of the Efficacy of Digital Breast Tomosynthesis Imaging". The primary objective of this protocol is to collect the 2-dimensional (2D) screening and diagnostic images, and 3-dimensional (3D) Digital Breast Tomosynthesis (DBT) scans from patient mammography examinations acquired on various commercially available Full Field Digital Mammography (FFDM) systems ...

What is the current status of trial NCT01373671?

This trial is currently completed. It is a NA study. The enrollment target is 764 participants. The study started on 2011-05. Estimated completion is 2014-05.

What conditions does trial NCT01373671 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01373671?

The interventions under investigation include: SIEMENS INSPIRATION DIGITAL BREAST TOMOSYNTHESIS (DBT) SYSTEM (DEVICE).

Who is sponsoring clinical trial NCT01373671?

This trial is sponsored by Siemens Medical Solutions USA - CSG, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01373671 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01373671's enrollment target sits among peer trials

764 148th of 1224 higher than 1,077 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04578665 · 764 participants · NA

    Human-like Robotic Controllers for Enhanced Motor Learning

  • NCT05579366 · 764 participants · Phase 1

    Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

  • NCT03789552 · 765 participants · Phase 3

    Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

  • NCT07195591 · 766 participants · Phase 3

    Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01373671, the US trial registry maintained by the National Library of Medicine. NCT01373671 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.